Developing column-free antibody purification for biologic drug manufacturing
Antibody purification commonly uses Protein A columns, which are costly, have limited binding capacity and require maintenance expertise. Emerging antibody formats also challenge existing purification infrastructure on scale, complexity and compatibility.
AromAb is developing APPC, a column-free antibody purification platform designed to operate at neutral pH. It aims to simplify biologic drug manufacturing for IgG, IgA, IgM and Fc-fusion proteins, with pilot-scale validation still a development objective.
What stands out about AromAb
AromAb joined the unlock_ Incubation Program in March 2026, supporting early-stage life sciences startups.
Co-founder Guy Patchornik invented APPC and heads the Antibody Purification Laboratory at Ariel University.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.